Business

May 13, 2014 10:18 AM

Heat Biologics reports $2.3 million first quarter loss

Heat Biologics reported a net loss in the first quarter as the small Chapel Hill drug-development prepares to begin Phase 2 trails for its lung cancer treatment later this year.

Related content

Suggested for you

Comments

Videos

Today's Market

Nasdaq
Powered by Barchart

Editor's Choice Videos

Raleigh Top Jobs

View All Top Jobs